In pursuit of full recovery in major depressive disorder

被引:4
|
作者
Vicent-Gil, M. [1 ]
Serra-Blasco, M. [2 ,3 ]
Navarra-Ventura, G. [4 ]
Trujols, J. [1 ]
Balanza-Martinez, V [5 ]
Portella, M. J. [1 ]
Cardoner, N. [1 ,4 ]
机构
[1] Univ Autonoma Barcelona UAB, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III CIBERSAM ISCIII,Hosp Santa, St Pau Mental Hlth Res Grp,Inst Invest Biomed St, Barcelona, Spain
[2] Hosp Duran I Reynals, Inst Catala Oncol, ICOnnectat E Hlth Program, Avinguda Granvia Hosp 199-203, Barcelona 08908, Spain
[3] Abat Oliba CEU Univ, Dept Psychol, Carrer Bellesguard 30, Barcelona 08022, Spain
[4] Univ Autonoma Barcelona UAB, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III CIBERSAM ISCIII,Hosp Univ P, Mental Hlth Dept,Inst Invest & Innovacio Parc Tau, Sabadell, Spain
[5] Univ Valencia, Ctr Invest Biomed Red Salud Mental CIBERSAM, Dept Med, Teaching Unit Psychiat & Psychol Med, Valencia, Spain
关键词
Cognition; Depression; Full recovery; Functional remission; Self-perceived remission; QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; RATING-SCALE; FUNCTIONAL IMPAIRMENT; UNIPOLAR DEPRESSION; EXECUTIVE FUNCTION; RESIDUAL SYMPTOMS; REMISSION STATUS; FOLLOW-UP; DEFICITS;
D O I
10.1007/s00406-022-01487-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Many individuals with major depression disorder (MDD) who achieve remission of depressive symptoms, do not perceive themselves as fully recovered. This study explores whether clinical remission is related to functional remission and to patient's perception of recovery, as well as, which factors are associated with their functional and subjective remission. 148 patients with MDD in partial clinical remission were included. Demographics and clinical variables were collected through semi-structured interviews. Objective cognition was evaluated through a neuropsychological battery and subjective cognition through a specific questionnaire. The patient's psychosocial functioning and the perception of their remission were also assessed. Apart from descriptive analysis, Pearson correlations and backward stepwise regression models explored the relationship between demographic, clinical, and cognitive factors with patients' functional and self-perceived remission. From the whole sample, 57 patients (38.5%) were considered to achieve full clinical remission, 38 patients (25.7%) showed functional remission, and 55 patients (37.2%) perceived themselves as remitted. Depressive symptoms and objective and subjective executive function were the factors associated with psychosocial functioning. Besides, depressive symptoms, objective and subjective attention, and subjective executive function were the significant explanatory variables for self-perception of remission. The concept of full recovery from an episode of MDD should not only include the clinician's perspective but also the patient's psychosocial functioning along with their self-perceived remission. As residual depressive symptoms and cognition (objective and subjective) are factors with great contribution to a full recovery, clinicians should specifically address them when choosing therapeutic strategies.
引用
收藏
页码:1095 / 1104
页数:10
相关论文
共 50 条
  • [41] Treatment for major depressive disorder
    Zhang, X.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 81 - 81
  • [42] SUMOylation and Major Depressive Disorder
    Jeoung, Seok-Won
    Park, Hyun-Sun
    Ryoo, Zae Young
    Cho, Dong-Hyung
    Lee, Hyun-Shik
    Ryu, Hong-Yeoul
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [43] Vilazodone In Major Depressive Disorder
    Frampton, James E.
    [J]. CNS DRUGS, 2011, 25 (07) : 615 - 627
  • [44] MAJOR DEPRESSIVE DISORDER AND IMMUNITY
    STEIN, M
    SCHLEIFER, SJ
    KELLER, SE
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 905 - 905
  • [45] MAJOR DEPRESSIVE DISORDER IN A PRESCHOOLER
    KASHANI, JH
    CARLSON, GA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1985, 24 (04): : 490 - 494
  • [46] VilazodoneIn Major Depressive Disorder
    James E. Frampton
    [J]. CNS Drugs, 2011, 25 : 615 - 627
  • [47] AripiprazoleIn Major Depressive Disorder
    Juliane Weber
    Katherine A. Lyseng-Williamson
    Lesley J. Scott
    [J]. CNS Drugs, 2008, 22 : 807 - 813
  • [48] Aripiprazole - In major depressive disorder
    Weber, Juliane
    Lyseng-Williamson, Katherine A.
    Scott, Lesley J.
    [J]. CNS DRUGS, 2008, 22 (10) : 807 - 813
  • [49] Neurobiology of Major Depressive Disorder
    Villanueva, Rosa
    [J]. NEURAL PLASTICITY, 2013, 2013
  • [50] Temperament and major depressive disorder
    Elie G Karam
    Mariana M Salamoun
    Joumana S Yeretzian
    Zeina Mneimneh
    Aimee N Karam
    John Fayyad
    [J]. Annals of General Psychiatry, 9 (Suppl 1)